Literature DB >> 19141436

The active form of the norovirus RNA-dependent RNA polymerase is a homodimer with cooperative activity.

Martin Högbom1, Katrin Jäger2, Ivonne Robel2, Torsten Unge3, Jacques Rohayem2.   

Abstract

Norovirus (NV) is a leading cause of gastroenteritis worldwide and a major public health concern. So far, the replication strategy of NV remains poorly understood, mainly because of the lack of a cell system to cultivate the virus. In this study, the function and the structure of a key viral enzyme of replication, the RNA-dependent RNA polymerase (RdRp, NS7), was examined. The overall structure of the NV NS7 RdRp was determined by X-ray crystallography to a 2.3 A (0.23 nm) resolution (PDB ID 2B43), displaying a right-hand fold typical of the template-dependent polynucleotide polymerases. Biochemical analysis evidenced that NV NS7 RdRp is active as a homodimer, with an apparent K(d) of 0.649 microM and a positive cooperativity (Hill coefficient n(H)=1.86). Crystals of the NV NS7 homodimer displayed lattices containing dimeric arrangements with high shape complementarity statistics. This experimental data on the structure and function of the NV RdRp may set the cornerstone for the development of polymerase inhibitors to control the infection with NV, a medically relevant pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141436     DOI: 10.1099/vir.0.005629-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases.

Authors:  Rowena A Bull; Jennifer Hyde; Jason M Mackenzie; Grant S Hansman; Tomoichiro Oka; Naokazu Takeda; Peter A White
Journal:  Virus Genes       Date:  2010-10-20       Impact factor: 2.332

2.  Interstitial contacts in an RNA-dependent RNA polymerase lattice.

Authors:  Andres B Tellez; Jing Wang; Elizabeth J Tanner; Jeannie F Spagnolo; Karla Kirkegaard; Esther Bullitt
Journal:  J Mol Biol       Date:  2011-08-03       Impact factor: 5.469

3.  Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Authors:  Auda A Eltahla; Kun Lee Lim; John-Sebastian Eden; Andrew G Kelly; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 4.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

5.  Guanylate-binding protein 2 orchestrates innate immune responses against murine norovirus and is antagonized by the viral protein NS7.

Authors:  Peifa Yu; Yang Li; Yunlong Li; Zhijiang Miao; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

6.  Application of Molecular Dynamics Simulations to the Design of Nucleotide Inhibitors Binding to Norovirus Polymerase.

Authors:  Holly Freedman; Juthika Kundu; Egor Petrovitch Tchesnokov; John Lok Man Law; James A Nieman; Raymond F Schinazi; D Lorne Tyrrell; Matthias Gotte; Michael Houghton
Journal:  J Chem Inf Model       Date:  2020-12-01       Impact factor: 4.956

7.  Surface for catalysis by poliovirus RNA-dependent RNA polymerase.

Authors:  Jing Wang; John M Lyle; Esther Bullitt
Journal:  J Mol Biol       Date:  2013-04-11       Impact factor: 5.469

Review 8.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

9.  High-resolution functional profiling of the norovirus genome.

Authors:  Lucy Thorne; Dalan Bailey; Ian Goodfellow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Phylogenetic prediction of cis-acting elements: a cre-like sequence in Norovirus genome?

Authors:  Matías Victoria; Rodney Colina; Marize Pereira Miagostovich; José P Leite; Juan Cristina
Journal:  BMC Res Notes       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.